Overview

Insulin Glulisine in Type 2 Diabetic Patients

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of a single injection of glulisine before the main meal added to insulin glargine plus oral antidiabetic drugs (OADs) compared to insulin glargine plus OADs in Type 2 diabetic patients poorly controlled with basal insulin plus OADs.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Glimepiride
Insulin
Insulin Glargine
Insulin glulisine
Insulin, Globin Zinc
Metformin